⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8267341 | 1.00 | — | — | |
| SCHEMBL13594908 | 0.75 | — | — | |
| SCHEMBL13662415 | 0.75 | — | — | |
| SCHEMBL14186113 | 0.75 | — | — | |
| SCHEMBL9977668 | 0.75 | — | — | |
| SCHEMBL13017767 | 0.73 | — | — | |
| SCHEMBL20125147 | 0.73 | — | — | |
| SCHEMBL9977635 | 0.71 | — | — | |
| SCHEMBL23395238 | 0.70 | — | — | |
| SCHEMBL9977645 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023176554-A1 | COGNITIVE-FUNCTION-IMPROVING AGENT | 国立大学法人東北大学 | 2023-09-21 | — | — | WO | disclosed |
| US-20230257389-A1 | SUBSTITUTED PYRIDOTRIAZINE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2023-08-17 | — | — | US | disclosed |
| US-11634396-B2 | Opioid receptor modulators | EPIODYNE, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| EP-4011877-A2 | METHOD OF TREATING ELEVATED PLASMA CHOLESTEROL | Institut de Cardiologie de Montréal (CA) | 2022-06-15 | — | — | EP | disclosed |
| US-20210053933-A1 | THERAPEUTIC AURONES | Middle Tennessee State University (US) | 2021-02-25 | — | — | US | disclosed |
| CN-108299314-A | Compound for treating Duchenne-Arandisease | PTC医疗公司 | 2018-07-20 | — | — | CN | disclosed |
| EP-2760854-B1 | IMIDAZOLE DERIVATIVES AS CYP17 INHIBITORS FOR THE TREATMENT OF CANCER | ASANA BIOSCIENCES LLC (US) | 2017-08-30 | — | — | EP | disclosed |
| WO-2017133681-A1 | TRICYCLIC COMPOUND FOR BROMODOMAIN-CONTAINING PROTEIN INHIBITOR AND PREPARATION, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | 正大天晴药业集团股份有限公司 | 2017-08-10 | — | — | WO | disclosed |
| EP-2933875-B1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ADSORBED ELECTRODE, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL | FUJIFILM CORP (JP) | 2017-03-29 | — | — | EP | disclosed |
| WO-2017035413-A2 | CARBAMATE, ESTER, AND KETONE COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| US-20090264404-A1 | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090256468-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-15 | — | — | US | disclosed |
| EP-2096108-A1 | Novel organic electroluminescent compounds and organic electroluminscent device using the same | Gracel Display Inc. (KR) | 2009-09-02 | — | — | EP | disclosed |
| EP-2028683-A1 | COATING LIQUID FOR GATE INSULATING FILM, GATE INSULATING FILM AND ORGANIC TRANSISTOR | Nissan Chemical Industries, Ltd. (JP) | 2009-02-25 | — | — | EP | disclosed |
| WO-2008042239-A2 | SOLID ELECTROLYTIC CAPACITOR AND METHOD OF MANUFACTURING THE SAME | NIPPON CHEMI-CON CORPORATION (JP) | 2008-04-10 | — | — | WO | disclosed |
| WO-2008039197-A1 | SOLID ELECTROLYTIC CAPACITOR AND METHOD OF MANUFACTURING THE SAME | NIPPON CHEMI-CON CORPORATION (JP) | 2008-04-03 | — | — | WO | disclosed |
| WO-2008039214-A1 | SOLID ELECTROLYTIC CAPACITOR AND METHOD OF MANUFACTURING THE SAME | NIPPON CHEMI-CON CORPORATION (JP) | 2008-04-03 | — | — | WO | disclosed |
| WO-2008008431-A2 | HETEROARYL SULFONAMIDES AND CCR2/CCR9 | CHEMOCENTRYX, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-0909288-B1 | PROCESS FOR CURING A POLYMERIZABLE COMPOSITION | CIBA SC HOLDING AG (CH) | 2007-06-27 | — | — | EP | disclosed |
| WO-2006098620-A1 | USE OF DERIVATIVES COMPRISING A COUMARIN GROUP FOR THE PREPARATION OF AN ANTIVIRAL AGENT, DERIVATIVES COMPRISING A COUMARIN GROUP, A METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RADEMAKER HOLDING B.V. (NL) | 2006-09-21 | — | — | WO | disclosed |